Line of treatment for heart attack

Reading File
Finding Sources
Finding Sources
Searching PubMed

"myocardial infarction"[MeSH Terms] AND "reperfusion"[MeSH Terms]

Reading File
Reading File
Reading File
Reading File
Finding Sources
Searching Images

STEMI treatment algorithm reperfusion pathway PCI fibrinolysis flowchart

This medical flowchart illustrates the reperfusion strategy selection and timeframes for patients with ST-elevation myocardial infarction (STEMI), based on 2018 ESC/EACTS Guidelines. The algorithm maps the 'Total Ischemia Time' from symptom onset, divided into 'Patient\'s Delay' and 'Health System\'s Delay'. Following a STEMI diagnosis (visualized by ST-segment elevation on ECG), the pathway bifurcates based on hospital capabilities. For hospitals with a catheterization lab (cath lab), the goal for Primary Percutaneous Coronary Intervention (PCI) is <60 minutes to guidewire introduction. For patients at hospitals without a cath lab or via emergency medical services, the decision depends on 'Time to PCI'. If the estimated PCI delay is ≤120 minutes, Primary PCI is preferred with a goal of <90 minutes. If the estimated delay is >120 minutes, immediate fibrinolysis (bolus) is indicated within 10 minutes. The diagram emphasizes minimizing 'Removal System\'s Delay' to ensure optimal myocardial revascularization and clinical outcomes.

This medical flowchart illustrates the reperfusion strategy selection and timeframes for patients with ST-elevation myocardial infarction (STEMI), based on 2018 ESC/EACTS Guidelines. The algorithm maps the 'Total Ischemia Time' from symptom onset, divided into 'Patient\'s Delay' and 'Health System\'s Delay'. Following a STEMI diagnosis (visualized by ST-segment elevation on ECG), the pathway bifurcates based on hospital capabilities. For hospitals with a catheterization lab (cath lab), the goal for Primary Percutaneous Coronary Intervention (PCI) is <60 minutes to guidewire introduction. For patients at hospitals without a cath lab or via emergency medical services, the decision depends on 'Time to PCI'. If the estimated PCI delay is ≤120 minutes, Primary PCI is preferred with a goal of <90 minutes. If the estimated delay is >120 minutes, immediate fibrinolysis (bolus) is indicated within 10 minutes. The diagram emphasizes minimizing 'Removal System\'s Delay' to ensure optimal myocardial revascularization and clinical outcomes.

Summary : This figure presents a care system pathway for patients experiencing ischemic symptoms suggestive of acute coronary syndrome (ACS), detailing the recommended steps for emergency medical services (EMS), hospital arrival, and reperfusion strategies based on the patient's mode of transportation and hospital capabilities.

flowchart:
# Nodes :
  • Start: Patients With Symptoms Suggestive of ACS (rectangle)
  • Patient calls 911: preferred (rectangle)
  • EMS obtains prehospital ECG within 10 min of FMC and suspects STEMI (Class 1) (rectangle)
  • EMS determines destination hospital (rectangle)
  • Transport to PCI center: Prehospital cath lab activation (Class 1), Direct transport to PCI center for PPCI (Class 1) (rectangle)
  • Arrive at PCI center (rectangle)
  • Bypass ED (if feasible) (rectangle)
  • ED (rectangle)
  • Cath lab (rectangle)
  • Goal EMS FMC-to-device ≤90 min (Class 1) (rectangle)
  • Primary PCI (rectangle)
  • Notify non-PCI center of STEMI patient en route (rectangle)
  • Arrive at non-PCI center (rectangle)
  • Non-PCI center commits to reperfusion strategy (rectangle)
  • Fibrinolysis strategy: If PPCI not feasible within 120 min of FMC (Class 1), Goal door-to-lysis ≤30 min (rectangle)
  • Assess patient for reperfusion after lysis (rectangle)
  • Arrange for immediate transfer to PCI center: If lysis failed or patient unstable, arrange for urgent angiography for rescue PCI (Class 1); If lysis successful and patient stable, arrange for early angiography (Class 1) (rectangle)
  • PPCI strategy: If PPCI feasible within 120 min of FMC, or lysis contraindicated (Class 1), Activate cath lab for PPCI, Urgent transfer to PCI center (bypass ED, direct to cath lab, if feasible) (rectangle)
  • Cath lab (rectangle)
  • Goal FMC-to-device ≤90 min (direct presenters) or ≤120 min (transfers) (Class 1) (rectangle)
  • Primary PCI (rectangle)
  • Patient takes own transportation (rectangle)
  • FMC: arrive at non-PCI center (rectangle)
  • Door-to-ECG ≤10 min (Class 1), Diagnose STEMI (rectangle)
  • FMC: arrive at PCI center (rectangle)
  • Door-to-ECG ≤10 min (Class 1), Diagnose STEMI, Activate cath lab (rectangle)

# Connectors :
  • Arrows indicate progression from symptom onset to EMS or self-transport, then to hospital arrival, diagnosis, and reperfusion strategy.
  • Branches split based on whether the patient calls 911 or self-transports, and whether the hospital is a PCI or non-PCI center.
  • Decision points include EMS determination of hospital, non-PCI center commitment to reperfusion strategy, and assessment after fibrinolysis.
  • Merges occur at the cath lab and primary PCI endpoints.

# Layout :
  • The flowchart is organized into three main vertical pathways: EMS/911 activation, self-transport to non-PCI center, and self-transport to PCI center.
  • Each pathway includes time-based goals (e.g., ECG within 10 min, FMC-to-device ≤90 min).
  • Green boxes highlight key actions and time targets.
  • The chart uses solid arrows for process flow and decision branches.

# Analysis :
  • The figure emphasizes rapid diagnosis and treatment for STEMI, with clear time goals for ECG, lysis, and PCI.
  • Direct transport to PCI centers and bypassing ED when feasible are prioritized for faster reperfusion.
  • Non-PCI centers must quickly commit to either fibrinolysis or transfer for PCI, with specific instructions based on patient stability and response.
  • The workflow is designed to minimize delays and optimize outcomes for ACS patients, regardless of initial hospital type or mode of arrival.

Summary : This figure presents a care system pathway for patients experiencing ischemic symptoms suggestive of acute coronary syndrome (ACS), detailing the recommended steps for emergency medical services (EMS), hospital arrival, and reperfusion strategies based on the patient's mode of transportation and hospital capabilities. flowchart: # Nodes : • Start: Patients With Symptoms Suggestive of ACS (rectangle) • Patient calls 911: preferred (rectangle) • EMS obtains prehospital ECG within 10 min of FMC and suspects STEMI (Class 1) (rectangle) • EMS determines destination hospital (rectangle) • Transport to PCI center: Prehospital cath lab activation (Class 1), Direct transport to PCI center for PPCI (Class 1) (rectangle) • Arrive at PCI center (rectangle) • Bypass ED (if feasible) (rectangle) • ED (rectangle) • Cath lab (rectangle) • Goal EMS FMC-to-device ≤90 min (Class 1) (rectangle) • Primary PCI (rectangle) • Notify non-PCI center of STEMI patient en route (rectangle) • Arrive at non-PCI center (rectangle) • Non-PCI center commits to reperfusion strategy (rectangle) • Fibrinolysis strategy: If PPCI not feasible within 120 min of FMC (Class 1), Goal door-to-lysis ≤30 min (rectangle) • Assess patient for reperfusion after lysis (rectangle) • Arrange for immediate transfer to PCI center: If lysis failed or patient unstable, arrange for urgent angiography for rescue PCI (Class 1); If lysis successful and patient stable, arrange for early angiography (Class 1) (rectangle) • PPCI strategy: If PPCI feasible within 120 min of FMC, or lysis contraindicated (Class 1), Activate cath lab for PPCI, Urgent transfer to PCI center (bypass ED, direct to cath lab, if feasible) (rectangle) • Cath lab (rectangle) • Goal FMC-to-device ≤90 min (direct presenters) or ≤120 min (transfers) (Class 1) (rectangle) • Primary PCI (rectangle) • Patient takes own transportation (rectangle) • FMC: arrive at non-PCI center (rectangle) • Door-to-ECG ≤10 min (Class 1), Diagnose STEMI (rectangle) • FMC: arrive at PCI center (rectangle) • Door-to-ECG ≤10 min (Class 1), Diagnose STEMI, Activate cath lab (rectangle) # Connectors : • Arrows indicate progression from symptom onset to EMS or self-transport, then to hospital arrival, diagnosis, and reperfusion strategy. • Branches split based on whether the patient calls 911 or self-transports, and whether the hospital is a PCI or non-PCI center. • Decision points include EMS determination of hospital, non-PCI center commitment to reperfusion strategy, and assessment after fibrinolysis. • Merges occur at the cath lab and primary PCI endpoints. # Layout : • The flowchart is organized into three main vertical pathways: EMS/911 activation, self-transport to non-PCI center, and self-transport to PCI center. • Each pathway includes time-based goals (e.g., ECG within 10 min, FMC-to-device ≤90 min). • Green boxes highlight key actions and time targets. • The chart uses solid arrows for process flow and decision branches. # Analysis : • The figure emphasizes rapid diagnosis and treatment for STEMI, with clear time goals for ECG, lysis, and PCI. • Direct transport to PCI centers and bypassing ED when feasible are prioritized for faster reperfusion. • Non-PCI centers must quickly commit to either fibrinolysis or transfer for PCI, with specific instructions based on patient stability and response. • The workflow is designed to minimize delays and optimize outcomes for ACS patients, regardless of initial hospital type or mode of arrival.

Summary : This flowchart outlines the decision-making and organization of reperfusion strategies for patients with ST-segment elevation myocardial infarction (STEMI) within the first 12 hours of medical contact, focusing on minimizing total ischemic time and system delays.

flowchart:
# Nodes :
  • Symptom onset (vertical dashed line, start point)
  • FMC STEMI diagnosis (vertical dashed line)
  • PCI centre (rectangle)
  • Primary PCI (rectangle, red)
  • Aim FMC-to-wire crossing time <60 mins (rectangle, red)
  • EMS or non-PCI centre (rectangle)
  • Can PCI be performed within 120 mins? (diamond)
  • Immediate transfer to PCI centre (rectangle)
  • Primary PCI (rectangle, red)
  • Aim FMC-to-wire crossing <90 mins (rectangle, red)
  • Immediate fibrinolysis (rectangle)
  • Aim FMC-to-needle time ≤30 mins (rectangle, red)
  • Fibrinolysis successful? (diamond)
  • Early transfer for coronary angiography between 2–24 hours (rectangle, red)
  • Immediate transfer for rescue PCI (rectangle, red)
  • If cardiogenic shock, immediate transfer to PCI centre where possible (rectangle, red, spanning bottom of chart)

# Connectors :
  • Arrows indicate flow from symptom onset through diagnosis to either PCI centre or EMS/non-PCI centre.
  • From PCI centre → Primary PCI → Aim FMC-to-wire crossing time <60 mins.
  • From EMS/non-PCI centre → Can PCI be performed within 120 mins?
    – YES: Immediate transfer to PCI centre → Primary PCI → Aim FMC-to-wire crossing <90 mins.
    – NO: Immediate fibrinolysis → Aim FMC-to-needle time ≤30 mins → Fibrinolysis successful?
      ▫ YES: Early transfer for coronary angiography between 2–24 hours.
      ▫ NO: Immediate transfer for rescue PCI.
  • If cardiogenic shock at any point, immediate transfer to PCI centre where possible.

# Layout :
  • Flow is left-to-right, with vertical swim-lanes for “Pathways and decisions in reperfusion” and “Time delays in reperfusion.”
  • Patient delay and system delay are indicated as horizontal bars below the main flowchart, contributing to total ischemic time.
  • Red boxes highlight critical time targets and urgent actions.

# Analysis :
  • The chart emphasizes minimizing delays in reperfusion therapy for STEMI, prioritizing primary PCI when feasible within recommended timeframes.
  • Decision points focus on the feasibility of PCI within 120 minutes and the success of fibrinolysis, with clear fallback strategies (rescue PCI or early angiography).
  • Immediate transfer to PCI centre is recommended in cases of cardiogenic shock, regardless of other considerations.
  • The flowchart visually separates patient delay from system delay, underscoring the importance of rapid system response to reduce total ischemic time.

Summary : This flowchart outlines the decision-making and organization of reperfusion strategies for patients with ST-segment elevation myocardial infarction (STEMI) within the first 12 hours of medical contact, focusing on minimizing total ischemic time and system delays. flowchart: # Nodes : • Symptom onset (vertical dashed line, start point) • FMC STEMI diagnosis (vertical dashed line) • PCI centre (rectangle) • Primary PCI (rectangle, red) • Aim FMC-to-wire crossing time <60 mins (rectangle, red) • EMS or non-PCI centre (rectangle) • Can PCI be performed within 120 mins? (diamond) • Immediate transfer to PCI centre (rectangle) • Primary PCI (rectangle, red) • Aim FMC-to-wire crossing <90 mins (rectangle, red) • Immediate fibrinolysis (rectangle) • Aim FMC-to-needle time ≤30 mins (rectangle, red) • Fibrinolysis successful? (diamond) • Early transfer for coronary angiography between 2–24 hours (rectangle, red) • Immediate transfer for rescue PCI (rectangle, red) • If cardiogenic shock, immediate transfer to PCI centre where possible (rectangle, red, spanning bottom of chart) # Connectors : • Arrows indicate flow from symptom onset through diagnosis to either PCI centre or EMS/non-PCI centre. • From PCI centre → Primary PCI → Aim FMC-to-wire crossing time <60 mins. • From EMS/non-PCI centre → Can PCI be performed within 120 mins? – YES: Immediate transfer to PCI centre → Primary PCI → Aim FMC-to-wire crossing <90 mins. – NO: Immediate fibrinolysis → Aim FMC-to-needle time ≤30 mins → Fibrinolysis successful? ▫ YES: Early transfer for coronary angiography between 2–24 hours. ▫ NO: Immediate transfer for rescue PCI. • If cardiogenic shock at any point, immediate transfer to PCI centre where possible. # Layout : • Flow is left-to-right, with vertical swim-lanes for “Pathways and decisions in reperfusion” and “Time delays in reperfusion.” • Patient delay and system delay are indicated as horizontal bars below the main flowchart, contributing to total ischemic time. • Red boxes highlight critical time targets and urgent actions. # Analysis : • The chart emphasizes minimizing delays in reperfusion therapy for STEMI, prioritizing primary PCI when feasible within recommended timeframes. • Decision points focus on the feasibility of PCI within 120 minutes and the success of fibrinolysis, with clear fallback strategies (rescue PCI or early angiography). • Immediate transfer to PCI centre is recommended in cases of cardiogenic shock, regardless of other considerations. • The flowchart visually separates patient delay from system delay, underscoring the importance of rapid system response to reduce total ischemic time.

Reading File
I now have comprehensive information. Let me compose the full, structured answer.

Line of Treatment for Heart Attack (Acute Myocardial Infarction)

Acute MI is classified into STEMI (ST-elevation MI) and NSTEMI (non-ST-elevation MI), because management differs significantly between them. The overarching principle is: restore blood flow as fast as possible, then stabilize and prevent recurrence.

Step 1 - Immediate / Pre-Hospital (First Medical Contact)

ActionDetail
12-lead ECGWithin 10 min of first medical contact
Aspirin (chewed)160-325 mg immediately; chewed for rapid buccal absorption
O2 supplementationOnly if SpO2 <90% - do NOT give routinely
Sublingual Nitroglycerin0.4 mg SL q5 min x3 for ongoing ischemic pain. Avoid if SBP <90 mmHg, suspected RV infarct, HR >100 or <50, or recent PDE-5 inhibitor use
IV access + monitoringContinuous cardiac monitoring; defibrillator ready
Morphine2-4 mg IV only for pain refractory to nitroglycerin (use cautiously - may slow oral drug absorption)
  • Harrison's Principles of Internal Medicine 22E, p.2163

Step 2 - Reperfusion Strategy (The Core of STEMI Treatment)

This is the cornerstone of STEMI management - time is myocardium.

2A. Primary PCI (Preferred Strategy)

  • Goal: First medical contact (FMC) to balloon/wire crossing ≤90 min (direct presenters) or ≤120 min (transfers)
  • PCI is preferred over fibrinolysis when achievable within these time windows
  • Patients at a non-PCI center should be urgently transferred if PCI can be done within 120 min of FMC

2B. Fibrinolysis (When PCI Not Feasible Within 120 Min)

  • Goal: Door-to-needle ≤30 min
  • Agents: tPA (alteplase), reteplase, tenecteplase (TNK) - fibrin-specific preferred
  • After successful fibrinolysis: transfer to PCI center for angiography at 3-24 hours
  • If fibrinolysis fails (persistent chest pain + ST elevation >90 min): Rescue PCI immediately
  • Cardiogenic shock: Transfer to PCI center regardless of other factors
STEMI Reperfusion Pathway - ESC/EACTS Guidelines
STEMI Care System Flowchart - AHA/ACC
  • Harrison's Principles of Internal Medicine 22E, pp. 2163-2164; Washington Manual of Medical Therapeutics, p.154

Step 3 - Antithrombotic Therapy (Given Early, With Reperfusion)

Antiplatelet Agents (Dual Antiplatelet Therapy - DAPT)

DrugRole
Aspirin160-325 mg loading, then 75-162 mg/day indefinitely
P2Y12 inhibitorAdd to aspirin (choose one):
- TicagrelorMore potent than clopidogrel; preferred in PCI
- PrasugrelMore potent; preferred if no prior stroke/TIA, age <75
- ClopidogrelStandard option, especially with fibrinolysis
GP IIb/IIIa inhibitors(e.g., abciximab, eptifibatide) - for thrombotic complications during PCI

Anticoagulants

DrugUse
Unfractionated Heparin (UFH)Preferred with primary PCI: 60 U/kg bolus (max 4000 U) then 12 U/kg/h infusion (max 1000 U/h); aPTT target 1.5-2x control
Enoxaparin (LMWH)Preferred with fibrinolysis; 30 mg IV bolus then 1 mg/kg SQ bid (if creatinine <2.5 mg/dL in men, <2 mg/dL in women); for ≤8 days
BivalirudinAlternative to UFH + GPIIb/IIIa; drug of choice in HIT patients; 0.75 mg/kg bolus then 1.75 mg/kg/h
FondaparinuxOption in NSTEMI; avoid in primary PCI (risk of catheter thrombosis)
  • Harrison's Principles of Internal Medicine 22E, pp. 2164-2165; Washington Manual, p.154

Step 4 - Additional Pharmacotherapy (STEMI & NSTEMI)

Beta-Blockers

  • Oral beta-blocker within 24 hours of STEMI in all patients WITHOUT:
    • Signs of new heart failure or cardiogenic shock (Killip class ≥II)
    • Age >70 years, SBP <120 mmHg, HR >110 or <60 bpm, advanced heart block
  • Reduce infarct size, prevent arrhythmias, and reduce mortality
  • IV beta-blockers: reserved only for arrhythmia control or acute hypertension (can increase mortality if given routinely in STEMI)

ACE Inhibitors / ARBs

  • Start within 24 hours of STEMI, especially if:
    • EF <40%, anterior infarction, hypertension, or diabetes
  • A large meta-analysis (ACE Inhibitor Myocardial Infarction Collaborative Group, 100,000 patients) demonstrated survival benefit
  • ARBs substituted if ACE inhibitor intolerant

Statins (High-Intensity)

  • Start high-intensity statin therapy (atorvastatin 40-80 mg or rosuvastatin 20-40 mg) early and continue long-term
  • LDL target <70 mg/dL (or <55 mg/dL in very high-risk patients)

Aldosterone Antagonists

  • Eplerenone or spironolactone for patients with EF ≤40% + HF symptoms or diabetes
  • Avoid if creatinine >2.5 mg/dL (men) or >2.0 mg/dL (women), or K+ >5 mEq/L

Step 5 - NSTEMI/UA-Specific Management

NSTEMI does NOT require immediate reperfusion in all cases. Risk stratification (TIMI or GRACE score) guides timing:
Risk CategoryApproach
Very high risk (ongoing ischemia, hemodynamic instability, refractory arrhythmia)Immediate invasive strategy (<2 hours)
High risk (elevated troponins, dynamic ECG changes, GRACE score >140)Early invasive strategy (<24 hours)
Intermediate riskInvasive strategy within 72 hours
Low riskNon-invasive risk stratification before discharge
DAPT + anticoagulation applies similarly to STEMI. Fibrinolytics are NOT used in NSTEMI.

Step 6 - Post-MI / Discharge Medications (Long-Term Secondary Prevention)

Drug ClassAgentDuration
AntiplateletAspirinLifelong
P2Y12 inhibitorTicagrelor or clopidogrel≥12 months post-ACS
Beta-blockerMetoprolol, carvedilolIndefinitely (especially if reduced EF)
ACE-I / ARBRamipril, lisinoprilIndefinitely
StatinAtorvastatin, rosuvastatinLifelong
Aldosterone antagonistEplerenoneIf EF ≤40% + HF/diabetes

Step 7 - Monitoring for Complications in Hospital

  • Arrhythmias: VF, VT, AV block - continuous monitoring; defibrillator/pacemaker ready
  • Heart failure / cardiogenic shock: Diuretics, vasopressors, intra-aortic balloon pump (IABP) or mechanical circulatory support
  • Pericarditis (Dressler syndrome): NSAIDs/colchicine
  • LV thrombus: Anticoagulation (warfarin or NOAC)
  • Mechanical complications: VSD, papillary muscle rupture, free wall rupture - surgical emergency

Summary Mnemonic: MONA-BASH (Acute Phase)

Morphine (pain control) | Oxygen (if SpO2 <90%) | Nitrates | Aspirin | Beta-blockers | Anticoagulants | Statins | Heparin

Sources: Harrison's Principles of Internal Medicine 22E (2025), Washington Manual of Medical Therapeutics, Goldman-Cecil Medicine, Fuster & Hurst's The Heart 15th Ed.

Pci.??

Finding Sources
Finding Sources
Searching Images

percutaneous coronary intervention PCI procedure coronary stent angioplasty diagram

This composite figure illustrates a percutaneous coronary intervention (PCI) procedure for in-stent restenosis (ISR). Panel 5a consists of two fluoroscopic frames showing balloon angioplasty (POBA) being performed to optimize a previously deployed stent in the Right Coronary Artery (RCA); a radiopaque balloon catheter is visible within the vessel lumen. Panel 5b presents cross-sectional Intravascular Ultrasound (IVUS) images, showing a circular, widely patent lumen with improved stent expansion and wall apposition following the intervention. The bright, circumferential echoes represent the expanded stent struts against the vessel wall. Panel 5c displays the final coronary angiogram, revealing an excellent procedural result with a smooth, unobstructed lumen in the RCA and successful restoration of distal blood flow without signs of residual stenosis or dissection. This sequence demonstrates the use of intravascular imaging to guide and verify successful balloon optimization in complex coronary revascularization cases.

This composite figure illustrates a percutaneous coronary intervention (PCI) procedure for in-stent restenosis (ISR). Panel 5a consists of two fluoroscopic frames showing balloon angioplasty (POBA) being performed to optimize a previously deployed stent in the Right Coronary Artery (RCA); a radiopaque balloon catheter is visible within the vessel lumen. Panel 5b presents cross-sectional Intravascular Ultrasound (IVUS) images, showing a circular, widely patent lumen with improved stent expansion and wall apposition following the intervention. The bright, circumferential echoes represent the expanded stent struts against the vessel wall. Panel 5c displays the final coronary angiogram, revealing an excellent procedural result with a smooth, unobstructed lumen in the RCA and successful restoration of distal blood flow without signs of residual stenosis or dissection. This sequence demonstrates the use of intravascular imaging to guide and verify successful balloon optimization in complex coronary revascularization cases.

This diagnostic fluoroscopic image captures a Percutaneous Coronary Intervention (PCI) during a 'kissing balloon' dilation procedure. The angiogram displays the bifurcation of the left main coronary artery into the left anterior descending (LAD) and left circumflex (LCx) arteries. Two radiopaque coronary stents with a visible mesh-like morphology are positioned in tandem, extending from the left main artery into the LAD and LCx branches. Two distinct coronary guidewires are seen traversing the length of the stents and extending into the distal vasculature. Notably, two angioplasty balloons are simultaneously inflated at the bifurcation to ensure optimal stent expansion and bifurcation patency. A large-bore catheter (Impella device) is also visible in the cardiac silhouette, providing hemodynamic support. The image demonstrates complex interventional techniques for treating coronary bifurcation lesions, highlighting the use of simultaneous balloon inflation to prevent side-branch occlusion and maintain vessel geometry.

This diagnostic fluoroscopic image captures a Percutaneous Coronary Intervention (PCI) during a 'kissing balloon' dilation procedure. The angiogram displays the bifurcation of the left main coronary artery into the left anterior descending (LAD) and left circumflex (LCx) arteries. Two radiopaque coronary stents with a visible mesh-like morphology are positioned in tandem, extending from the left main artery into the LAD and LCx branches. Two distinct coronary guidewires are seen traversing the length of the stents and extending into the distal vasculature. Notably, two angioplasty balloons are simultaneously inflated at the bifurcation to ensure optimal stent expansion and bifurcation patency. A large-bore catheter (Impella device) is also visible in the cardiac silhouette, providing hemodynamic support. The image demonstrates complex interventional techniques for treating coronary bifurcation lesions, highlighting the use of simultaneous balloon inflation to prevent side-branch occlusion and maintain vessel geometry.

This composite of three diagnostic fluoroscopic images illustrates a percutaneous coronary intervention (PCI) procedure, specifically demonstrating Left Main (LM) coronary artery stenting using the kissing balloon technique. The left panel shows a coronary angiogram in an RAO Caudal projection (spider view), providing clear visualization of the distal left main bifurcation into the left anterior descending (LAD) and circumflex (LCx) arteries with contrast enhancement. The central panel captures the interventional phase in an LAO Cranial projection, showing a catheter-delivered angioplasty balloon inflated at the bifurcation site; the balloon is identifiable by distinct radiopaque markers, with a distal guidewire curving beyond the tip. The right panel displays the post-stent result in an LAO Cranial projection, demonstrating restored vessel patency and the structural deployment of the stent. These images serve as an educational resource for interventional cardiology, highlighting procedural steps for complex bifurcation lesions and coronary anatomy visualization.

This composite of three diagnostic fluoroscopic images illustrates a percutaneous coronary intervention (PCI) procedure, specifically demonstrating Left Main (LM) coronary artery stenting using the kissing balloon technique. The left panel shows a coronary angiogram in an RAO Caudal projection (spider view), providing clear visualization of the distal left main bifurcation into the left anterior descending (LAD) and circumflex (LCx) arteries with contrast enhancement. The central panel captures the interventional phase in an LAO Cranial projection, showing a catheter-delivered angioplasty balloon inflated at the bifurcation site; the balloon is identifiable by distinct radiopaque markers, with a distal guidewire curving beyond the tip. The right panel displays the post-stent result in an LAO Cranial projection, demonstrating restored vessel patency and the structural deployment of the stent. These images serve as an educational resource for interventional cardiology, highlighting procedural steps for complex bifurcation lesions and coronary anatomy visualization.

This composite of diagnostic images contains four panels (Fig 8a-d) showing a percutaneous coronary intervention (PCI) procedure for in-stent restenosis (ISR). Panel 8a is a coronary angiogram of the right coronary artery (RCA) displaying a complete occlusion within a previously placed proximal stent. Retrograde collateral vessels are visible, arising from the left coronary artery to supply the distal RCA. Panel 8b illustrates the successful antegrade advancement of a guidewire across the occluded segment into the distal vessel, confirmed via contralateral injection. Panels 8c and 8d demonstrate the therapeutic phase of the procedure, featuring predilatation of the occluded stented segment using non-compliant balloons. The balloons are seen fully inflated across the lesion site to restore luminal patency before further definitive treatment. This series provides a clinical example of managing complex chronic total occlusions within previously stented segments using antegrade techniques and high-pressure balloon angioplasty.

This composite of diagnostic images contains four panels (Fig 8a-d) showing a percutaneous coronary intervention (PCI) procedure for in-stent restenosis (ISR). Panel 8a is a coronary angiogram of the right coronary artery (RCA) displaying a complete occlusion within a previously placed proximal stent. Retrograde collateral vessels are visible, arising from the left coronary artery to supply the distal RCA. Panel 8b illustrates the successful antegrade advancement of a guidewire across the occluded segment into the distal vessel, confirmed via contralateral injection. Panels 8c and 8d demonstrate the therapeutic phase of the procedure, featuring predilatation of the occluded stented segment using non-compliant balloons. The balloons are seen fully inflated across the lesion site to restore luminal patency before further definitive treatment. This series provides a clinical example of managing complex chronic total occlusions within previously stented segments using antegrade techniques and high-pressure balloon angioplasty.

Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
I have the core PCI content from Harrison's (lines 554-630). The first read already captured the PCI section. Let me now compile the full, detailed answer.

Percutaneous Coronary Intervention (PCI)

What is PCI?

PCI (also called coronary angioplasty) is a catheter-based procedure used to open blocked or narrowed coronary arteries without open-heart surgery. It involves balloon dilatation of the stenosed vessel, almost always accompanied by coronary stenting to keep the artery open. It is the preferred reperfusion method in STEMI and is widely used for stable ischemic heart disease (IHD) and NSTEMI.
  • Harrison's Principles of Internal Medicine 22E, p.2148

Types of PCI

TypeDescription
Primary PCIDone emergently for STEMI without prior fibrinolysis - the gold standard reperfusion strategy
Elective / Scheduled PCIFor stable angina or significant coronary stenosis identified on angiography
Rescue PCIDone after failed fibrinolysis (persistent pain + ST elevation >90 min)
Facilitated PCIPCI performed after pharmacologic therapy (GPI or lytics) as a bridge - largely abandoned
Staged PCITreating non-culprit vessels in a separate session after primary PCI for STEMI

Step-by-Step Procedure

1. Vascular Access

  • Radial artery (preferred - lower bleeding risk, earlier ambulation)
  • Femoral artery (alternative - used in complex anatomy or hemodynamic instability)
  • A sheath (5-8 Fr) is inserted via modified Seldinger technique

2. Guide Catheter Placement

  • A guide catheter is advanced through the aorta to the ostium of the target coronary artery (left or right)
  • Coronary angiography is performed with contrast to identify and characterize the lesion

3. Guidewire Crossing

  • A thin coronary guidewire (0.014 inch) is carefully advanced across the stenosis or occlusion
  • This wire acts as a "rail" for subsequent devices

4. Balloon Predilatation (optional)

  • A balloon catheter is advanced over the wire and inflated at the lesion site
  • Compresses the plaque and prepares the vessel for stent delivery

5. Stent Deployment

  • A stent (crimped on a balloon catheter) is advanced to the lesion and inflated
  • The balloon expands the stent against the vessel wall, restoring the lumen

6. Post-dilatation (if needed)

  • A high-pressure non-compliant balloon inflated inside the deployed stent ensures full apposition

7. Final Angiography

  • Confirms TIMI 3 flow (full restoration of blood flow), no dissection, no residual stenosis

Types of Stents

Stent TypeDetails
Bare Metal Stent (BMS)First generation; higher restenosis rate (due to neointimal hyperplasia); DAPT for 1 month
Drug-Eluting Stent (DES)Current standard of care; coated with sirolimus/paclitaxel derivatives to inhibit smooth muscle cell proliferation; restenosis rate <5%; DAPT for 12 months
Bioresorbable Vascular Scaffold (BVS)Absorbable stent; less used currently due to higher thrombosis rates
Drug-eluting stents reduce restenosis dramatically compared to bare metal stents, but their delayed endothelial healing extends the mandatory DAPT period. - Harrison's, p.2148
PCI - Balloon angioplasty and stent deployment in RCA

Indications for PCI

  • STEMI: Primary reperfusion of choice (FMC-to-wire ≤90 min)
  • NSTEMI/UA: High-risk patients with elevated troponins, dynamic ECG changes, ongoing ischemia
  • Stable IHD: Significant stenosis (>70%) causing ischemia on stress testing, refractory to optimal medical therapy
  • One or two-vessel disease: PCI preferred over CABG
  • Selected three-vessel disease: PCI may be appropriate in certain anatomies (SYNTAX score-guided)

When CABG is Preferred Over PCI

SituationReason
Left main coronary artery diseaseHigh-risk anatomy; CABG provides more complete revascularization
Three-vessel disease + diabetesCABG shows superior long-term outcomes (FREEDOM trial)
Three-vessel disease + reduced EFCABG offers survival benefit
Vessels unsuitable for stentingHeavily calcified, tortuous, or diffusely diseased vessels
Failed PCI / complicationsSurgical bailout
  • Harrison's, p.2148

Pre-Procedure Medications

DrugPurpose
Aspirin 325 mgAntiplatelet - given before PCI
P2Y12 inhibitor (ticagrelor or prasugrel preferred; clopidogrel alternative)Dual antiplatelet - loading dose before or at time of PCI
UFH or bivalirudinAnticoagulation during the procedure
GP IIb/IIIa inhibitors(abciximab, eptifibatide) - for high thrombus burden or thrombotic complications

Post-PCI Management

ItemDetail
DAPT (Dual Antiplatelet Therapy)Aspirin + ticagrelor/clopidogrel for ≥12 months after DES in ACS; 6 months in stable disease
StatinHigh-intensity (atorvastatin 40-80 mg) - continue lifelong
Beta-blockerContinue if reduced EF or post-MI
ACE inhibitor/ARBContinue if reduced EF, hypertension, or diabetes
Access site careRadial band (if radial) or compression + bed rest (if femoral)
Renal monitoringContrast nephropathy - hydration, avoid NSAIDs post-procedure

Complications of PCI

ComplicationNotes
In-stent restenosisNeointimal hyperplasia; <5% with DES; treated with repeat PCI (drug-coated balloon)
Stent thrombosisRare but life-threatening; early (≤30 days) or late (>30 days); risk rises with premature DAPT cessation
Coronary dissectionMay require additional stenting
No-reflow / slow-flowMicrovascular embolization; treat with adenosine/verapamil IC
Contrast nephropathyPre-hydrate; minimize contrast volume
Vascular access complicationsHematoma, pseudoaneurysm, AV fistula (femoral > radial)
PerforationRare; may cause tamponade - needs pericardiocentesis or surgery
Radiation exposureMinimized by fluoroscopy time reduction

Key Time Targets (Primary PCI for STEMI)

ScenarioTarget
Direct presentation to PCI centerFMC-to-wire ≤90 min
Transfer from non-PCI centerFMC-to-wire ≤120 min
At PCI center, door-to-balloon≤60 min
If fibrinolysis given first, angiography3-24 hours later

Adjunctive Tools Used During PCI

ToolUse
IVUS (Intravascular Ultrasound)Assess plaque, optimize stent sizing and apposition
OCT (Optical Coherence Tomography)High-resolution plaque characterization
FFR/iFR (Fractional Flow Reserve)Assess hemodynamic significance of intermediate lesions
Rotablation / AtherectomyCalcified lesions unamenable to balloon dilatation
ThrombectomyAspiration of large thrombus in STEMI
PCI - Kissing balloon technique for left main bifurcation

Sources: Harrison's Principles of Internal Medicine 22E (2025), Washington Manual of Medical Therapeutics, Goodman & Gilman's Pharmacological Basis of Therapeutics

What are the differences between CABG and PCI for multivessel disease?

Finding Sources
Finding Sources
Searching PubMed

"coronary artery bypass"[MeSH Terms] AND "percutaneous coronary intervention"[MeSH Terms] AND "multivessel"

Reading File
Finding Sources
Reading Article

PMID: 40174598

Finding Sources
Reading Article

PMID: 40072460

Searching Images

CABG versus PCI comparison multivessel coronary artery disease outcomes diagram

Diagnostic coronary angiography images comparing two clinical scenarios of coronary artery disease. The image is structured into two horizontal rows, each containing three angiographic views (likely RAO/LAO cranial and caudal projections) to visualize the Right Coronary Artery (RCA), Left Anterior Descending (LAD) artery, and Circumflex (LCx) artery. Scenario 1 (top row) demonstrates high-complexity multivessel disease with a total SYNTAX score of 47. Labeled lesions include the mid-RCA, distal RCA, posterolateral branch, distal circumflex, first diagonal, and mid-LAD, showing varying degrees of stenosis and vessel involvement. Scenario 2 (bottom row) illustrates low-complexity disease with a total SYNTAX score of 10, highlighting fewer and less severe lesions in the distal RCA, distal circumflex, and mid-LAD. These comparison images serve as an educational tool for cardiologists to understand coronary lesion scoring based on anatomical location, severity, and complexity to guide revascularization strategies (PCI vs. CABG).

Diagnostic coronary angiography images comparing two clinical scenarios of coronary artery disease. The image is structured into two horizontal rows, each containing three angiographic views (likely RAO/LAO cranial and caudal projections) to visualize the Right Coronary Artery (RCA), Left Anterior Descending (LAD) artery, and Circumflex (LCx) artery. Scenario 1 (top row) demonstrates high-complexity multivessel disease with a total SYNTAX score of 47. Labeled lesions include the mid-RCA, distal RCA, posterolateral branch, distal circumflex, first diagonal, and mid-LAD, showing varying degrees of stenosis and vessel involvement. Scenario 2 (bottom row) illustrates low-complexity disease with a total SYNTAX score of 10, highlighting fewer and less severe lesions in the distal RCA, distal circumflex, and mid-LAD. These comparison images serve as an educational tool for cardiologists to understand coronary lesion scoring based on anatomical location, severity, and complexity to guide revascularization strategies (PCI vs. CABG).

Summary : This image presents a clinical recommendation table for DAPT (dual antiplatelet therapy) adherence in patients with multivessel coronary artery disease (CAD), comparing PCI (percutaneous coronary intervention) and CABG (coronary artery bypass grafting).

table:
# Recommendation Table for DAPT Adherence :

## Columns :
• COR (Class of Recommendation): 2a (yellow background)
• LOE (Level of Evidence): B-NR (blue background)
• RECOMMENDATION: Textual clinical recommendation

## Recommendation Text :
• "In patients with multivessel CAD amenable to treatment with either PCI or CABG who are unable to access, tolerate, or adhere to DAPT for the appropriate duration of treatment, CABG is reasonable in preference to PCI (1-10)."

## Supplementary Information :
• Referenced studies supporting the recommendation are summarized in "Online Data Supplement 16."

Analysis :
• The table provides a specific clinical recommendation (Class 2a, Level B-NR) suggesting CABG over PCI for patients with multivessel CAD who cannot adhere to DAPT, with supporting references available in an online supplement. The structure is typical for guideline tables, with clear separation of recommendation strength, evidence level, and clinical context.

Summary : This image presents a clinical recommendation table for DAPT (dual antiplatelet therapy) adherence in patients with multivessel coronary artery disease (CAD), comparing PCI (percutaneous coronary intervention) and CABG (coronary artery bypass grafting). table: # Recommendation Table for DAPT Adherence : ## Columns : • COR (Class of Recommendation): 2a (yellow background) • LOE (Level of Evidence): B-NR (blue background) • RECOMMENDATION: Textual clinical recommendation ## Recommendation Text : • "In patients with multivessel CAD amenable to treatment with either PCI or CABG who are unable to access, tolerate, or adhere to DAPT for the appropriate duration of treatment, CABG is reasonable in preference to PCI (1-10)." ## Supplementary Information : • Referenced studies supporting the recommendation are summarized in "Online Data Supplement 16." Analysis : • The table provides a specific clinical recommendation (Class 2a, Level B-NR) suggesting CABG over PCI for patients with multivessel CAD who cannot adhere to DAPT, with supporting references available in an online supplement. The structure is typical for guideline tables, with clear separation of recommendation strength, evidence level, and clinical context.

Summary : This table presents recommendations for patients with complex coronary artery disease (CAD) who require revascularization, comparing coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) based on disease complexity and supporting evidence.

table:
# Columns :
  • COR (Class of Recommendation): 1 (green), 2a (yellow)
  • LOE (Level of Evidence): B-R (randomized)
  • RECOMMENDATIONS: Detailed clinical guidance for each scenario

# Rows :
  • Row 1: 
    – COR: 1 (green)
    – LOE: B-R
    – Recommendation: In patients who require revascularization for significant left main CAD with high-complexity CAD, it is recommended to choose CABG over PCI to improve survival (references 1,2).
  • Row 2:
    – COR: 2a (yellow)
    – LOE: B-R
    – Recommendation: In patients who require revascularization for multivessel CAD with complex or diffuse CAD (e.g., SYNTAX score >33), it is reasonable to choose CABG over PCI to confer a survival advantage (references 2-5).

# Design Encodings :
  • COR is color-coded: green for 1, yellow for 2a.
  • LOE is consistently B-R (randomized evidence).
  • Recommendations are text-based, with reference numbers in parentheses.

# Analysis :
  • The table prioritizes CABG over PCI for patients with high-complexity or multivessel CAD, especially when left main disease or high SYNTAX scores are present.
  • Stronger recommendation (Class 1) is given for left main CAD with high complexity, while a reasonable (Class 2a) recommendation is given for multivessel or diffuse CAD.
  • Both recommendations are supported by randomized evidence (B-R).

Summary : This table presents recommendations for patients with complex coronary artery disease (CAD) who require revascularization, comparing coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) based on disease complexity and supporting evidence. table: # Columns : • COR (Class of Recommendation): 1 (green), 2a (yellow) • LOE (Level of Evidence): B-R (randomized) • RECOMMENDATIONS: Detailed clinical guidance for each scenario # Rows : • Row 1: – COR: 1 (green) – LOE: B-R – Recommendation: In patients who require revascularization for significant left main CAD with high-complexity CAD, it is recommended to choose CABG over PCI to improve survival (references 1,2). • Row 2: – COR: 2a (yellow) – LOE: B-R – Recommendation: In patients who require revascularization for multivessel CAD with complex or diffuse CAD (e.g., SYNTAX score >33), it is reasonable to choose CABG over PCI to confer a survival advantage (references 2-5). # Design Encodings : • COR is color-coded: green for 1, yellow for 2a. • LOE is consistently B-R (randomized evidence). • Recommendations are text-based, with reference numbers in parentheses. # Analysis : • The table prioritizes CABG over PCI for patients with high-complexity or multivessel CAD, especially when left main disease or high SYNTAX scores are present. • Stronger recommendation (Class 1) is given for left main CAD with high complexity, while a reasonable (Class 2a) recommendation is given for multivessel or diffuse CAD. • Both recommendations are supported by randomized evidence (B-R).

I now have excellent content from Goldman-Cecil, FAME 3 (Lancet 2025), the FAME 3 diabetes subgroup (JAMA Cardiology 2025), and ACC/AHA guideline images. Let me compile the comprehensive answer.

CABG vs PCI for Multivessel Coronary Artery Disease


Overview

Both CABG and PCI achieve coronary revascularization, but they differ fundamentally in approach, completeness, durability, and which patient populations benefit most. The choice is guided by coronary anatomy complexity (SYNTAX score), LV function, diabetes status, comorbidities, and patient preference.

Head-to-Head Comparison

FeaturePCICABG
ApproachCatheter-based, percutaneousOpen-heart surgery with cardiopulmonary bypass
InvasivenessMinimally invasiveMajor surgery
Recovery timeHours to days4-6 weeks
Procedural mortality0.5-1%1-3% (higher baseline risk)
Stroke riskLower (~0.5-1%)Higher (~1.5-2%)
Completeness of revascularizationIncomplete in complex/diffuse diseaseMore complete (bypasses segments, not just focal stenoses)
Repeat revascularizationHigher (10-16% at 5 years)Lower (7-8% at 5 years)
MI risk long-termHigherLower
Survival (simple 1-2 vessel disease)Equivalent to CABGEquivalent to PCI
Survival (complex multivessel / LM)Inferior in high SYNTAX scoreSuperior
Survival (3-vessel + diabetes)InferiorSuperior (FREEDOM trial)
DAPT requirement6-12 months minimumNot required (aspirin alone)
Graft/stent durabilityDES: >5 years; in-stent restenosis <5%IMA graft: >90% patent at 10 years

The SYNTAX Score - The Key Anatomical Guide

The SYNTAX score quantifies coronary disease complexity based on lesion location, severity, and morphology. It is the most important tool for deciding PCI vs CABG.
SYNTAX ScoreCoronary ComplexityPreferred Strategy
Low (<23)Simple/limited diseasePCI acceptable; similar outcomes to CABG
Intermediate (23-32)Moderate complexityHeart team discussion; CABG often preferred
High (≥33)Complex/diffuse diseaseCABG preferred - survival advantage
SYNTAX score comparison - high (47) vs low (10) complexity coronary disease

ACC/AHA Guideline Recommendations

ACC/AHA Guideline table - CABG vs PCI for complex CAD
Clinical ScenarioRecommendationClass / LOE
Left main CAD + high-complexity diseaseCABG over PCI to improve survivalClass I / B-R
Multivessel CAD + SYNTAX score >33CABG over PCI - survival advantageClass IIa / B-R
Unable to tolerate/adhere to DAPTCABG over PCI - reasonableClass IIa / B-NR
ACS / STEMI (acute setting)PCI preferred as initial strategyClass I
STEMI with failed PCI or residual ischemiaCABG as rescueClass I
  • Goldman-Cecil Medicine, p.653

Special Populations

Diabetes + Multivessel Disease

The FREEDOM trial (classic landmark) demonstrated a clear survival advantage of CABG over PCI in diabetics with multivessel disease. The recently published FAME 3 diabetes subgroup (JAMA Cardiology, 2025) (PMID 40072460) adds nuance:
  • At 3 years, CABG had fewer MACCE than FFR-guided PCI in patients with diabetes (HR 1.44; 95% CI 0.91-2.28) - though not statistically significant
  • In patients with SYNTAX score ≥23, PCI had higher MACCE than CABG regardless of diabetes status
  • At low SYNTAX score (<23), no significant difference between PCI and CABG even in diabetics
The older teaching that "diabetes = always CABG" is now more nuanced: SYNTAX score matters more than diabetes status alone.

Reduced LV Function (EF <35%)

  • CABG is preferred - provides complete revascularization and improves survival in hibernating myocardium
  • The STICH trial confirmed CABG survival benefit over medical therapy in ischemic cardiomyopathy

Left Main Disease

  • High complexity (extensive additional disease): CABG strongly preferred (Class I)
  • Low complexity (isolated LM or LM + limited disease): PCI is a reasonable alternative; lower stroke risk with PCI but higher repeat revascularization
  • Goldman-Cecil, p.524

FAME 3 Trial - Most Recent 5-Year Data (Lancet, 2025)

The FAME 3 trial 5-year follow-up (Lancet, 2025) (PMID 40174598) is the most current evidence comparing FFR-guided PCI (with modern zotarolimus-eluting stents) vs CABG in 3-vessel disease (no left main):
Outcome at 5 yearsPCICABGHR (95% CI)
Death + stroke + MI (composite)16%14%1.16 (0.89-1.52), p=0.27 (NS)
Death7%7%0.99 (0.67-1.46)
Stroke2%3%0.65 (0.33-1.28)
MI8%5%1.57 (1.04-2.36) ↑ PCI
Repeat revascularization16%8%2.02 (1.46-2.79) ↑ PCI
Key takeaway from FAME 3: With modern FFR-guided PCI and current-generation stents, overall survival at 5 years is equivalent to CABG in 3-vessel disease - but MI and repeat revascularization remain significantly higher with PCI.

Why CABG Has a Biological Advantage in Complex Disease

  1. Internal thoracic artery (ITA/IMA) grafts bypass the diseased segment and tap into a healthy arterial conduit - superior patency (>90% at 10 years) vs saphenous vein grafts or stents
  2. Bypasses the entire diseased segment - not just the focal stenosis, protecting against future plaque rupture in the same vessel
  3. Complete revascularization of all major territories in a single procedure
  4. In complex/diffuse disease, there may be lesions too distal, too calcified, or too tortuous for stenting - CABG can reach them

Why PCI May Be Preferred in Certain Patients

  1. High surgical risk (poor candidate for general anesthesia, frailty, severe COPD)
  2. Prior CABG with patent IMA graft (re-do CABG is high risk; PCI of vein graft or native vessel is safer)
  3. Patient refusal of surgery
  4. Acute coronary syndrome / STEMI (speed of reperfusion)
  5. Limited disease (1-2 vessel, low SYNTAX score)
  6. No DAPT contraindication

Heart Team Decision-Making

Current guidelines recommend a multidisciplinary Heart Team (interventional cardiologist + cardiac surgeon + referring cardiologist) for all complex multivessel disease decisions. This is especially important for:
  • SYNTAX score ≥22
  • Left main disease
  • Reduced EF
  • Diabetic patients with 3-vessel disease

Summary Decision Framework

Multivessel Disease
├── ACS / STEMI → PCI (primary reperfusion)
├── Stable + Low SYNTAX (<23) → PCI or CABG (equivalent)
├── Stable + Intermediate SYNTAX (23-32) → Heart Team; lean CABG
├── Stable + High SYNTAX (≥33) → CABG preferred
├── Left main + high complexity → CABG (Class I)
├── Left main + low complexity → PCI acceptable
├── 3-vessel + Diabetes + SYNTAX ≥23 → CABG preferred
├── Reduced EF (<35%) → CABG preferred
└── Cannot tolerate DAPT → CABG preferred

Sources: Goldman-Cecil Medicine (Elsevier); Harrison's Principles of Internal Medicine 22E; FAME 3 trial - Lancet 2025 (PMID 40174598); FAME 3 diabetes subgroup - JAMA Cardiology 2025 (PMID 40072460); ACC/AHA Coronary Revascularization Guidelines

12 lead ecg

Finding Sources
Finding Sources
Searching Images

12 lead ECG electrode placement chest limb leads diagram

A clinical photograph illustrating the standardized placement of a 12-lead electrocardiogram (ECG) on a neonate. The image shows several electrodes secured to the newborn's skin using clear adhesive gel tabs (Philips brand). The electrode distribution follows neonatology guidelines to minimize motion artifacts: the four limb leads are positioned on the right and left shoulders and the right and left iliac crests, rather than the distal extremities. The precordial leads (V1-V6) are arranged across the anterior chest wall. Each electrode consists of a transparent plastic clip housing, a tapered brown connector with color-coded bands (including red, yellow, green, blue, and purple) for lead identification, and white cabling. The clinical context demonstrates the procedural adaptations required for neonatal cardiac monitoring, such as using torso placement for limb leads to improve signal-to-noise ratio in active infants.

A clinical photograph illustrating the standardized placement of a 12-lead electrocardiogram (ECG) on a neonate. The image shows several electrodes secured to the newborn's skin using clear adhesive gel tabs (Philips brand). The electrode distribution follows neonatology guidelines to minimize motion artifacts: the four limb leads are positioned on the right and left shoulders and the right and left iliac crests, rather than the distal extremities. The precordial leads (V1-V6) are arranged across the anterior chest wall. Each electrode consists of a transparent plastic clip housing, a tapered brown connector with color-coded bands (including red, yellow, green, blue, and purple) for lead identification, and white cabling. The clinical context demonstrates the procedural adaptations required for neonatal cardiac monitoring, such as using torso placement for limb leads to improve signal-to-noise ratio in active infants.

This composite educational graphic illustrates the procedural setup and resulting data for a standard 12-lead electrocardiogram (ECG/EKG). Panels (a) and (b) are clinical photographs demonstrating correct electrode placement on a male torso. The limb leads are positioned as RA (right arm/shoulder) and LA (left arm/shoulder) on the upper chest, with RL (right leg) and LL (left leg) on the lower abdomen. The precordial leads (V1-V6) follow the standard anatomical arc across the chest: V1 and V2 at the fourth intercostal space (right and left of the sternum), V4 at the fifth intercostal space (mid-clavicular line), and V3, V5, and V6 completing the transverse sequence toward the left axilla. Panel (a) includes an inset showing the experimental use of conductive carbon nanotube yarns (SWNT-CYs) connected via alligator clips to the electrodes. Panel (c) displays the resulting 12-lead ECG waveforms on a standard grid, labeled I, II, III, aVR, aVL, aVF, and V1-V6. Each lead shows distinct P-waves, QRS complexes, and T-waves, representing different electrical vectors of cardiac depolarization and repolarization.

This composite educational graphic illustrates the procedural setup and resulting data for a standard 12-lead electrocardiogram (ECG/EKG). Panels (a) and (b) are clinical photographs demonstrating correct electrode placement on a male torso. The limb leads are positioned as RA (right arm/shoulder) and LA (left arm/shoulder) on the upper chest, with RL (right leg) and LL (left leg) on the lower abdomen. The precordial leads (V1-V6) follow the standard anatomical arc across the chest: V1 and V2 at the fourth intercostal space (right and left of the sternum), V4 at the fifth intercostal space (mid-clavicular line), and V3, V5, and V6 completing the transverse sequence toward the left axilla. Panel (a) includes an inset showing the experimental use of conductive carbon nanotube yarns (SWNT-CYs) connected via alligator clips to the electrodes. Panel (c) displays the resulting 12-lead ECG waveforms on a standard grid, labeled I, II, III, aVR, aVL, aVF, and V1-V6. Each lead shows distinct P-waves, QRS complexes, and T-waves, representing different electrical vectors of cardiac depolarization and repolarization.

This procedural clinical photograph demonstrates the concurrent placement of a standard 12-lead electrocardiogram (ECG) and a Polar H10 heart rate sensor chest strap on a male subject. The image illustrates proper anatomical positioning for clinical and exercise physiology monitoring. The six precordial leads (V1-V6) are visible across the chest: V1 (4th intercostal space, right sternal border), V2 (4th intercostal space, left sternal border), V3 (midway between V2 and V4), V4 (5th intercostal space, mid-clavicular line), V5 (anterior axillary line), and V6 (mid-axillary line). The leads utilize standard color-coding (Red, Yellow, Green, Brown, Black, Violet). Limb leads are positioned at the shoulders (RA/LA) and the lower ribcage/abdominal area (RL/LL) to facilitate movement during testing. The Polar H10 chest strap is situated inferior to the pectoral muscles, intersecting the mid-precordial electrode line. This visual serves as an educational reference for electrode application in comparative heart rate variability (HRV) studies, highlighting the spatial relationship between traditional medical grade ECG sensors and wearable consumer fitness technology.

This procedural clinical photograph demonstrates the concurrent placement of a standard 12-lead electrocardiogram (ECG) and a Polar H10 heart rate sensor chest strap on a male subject. The image illustrates proper anatomical positioning for clinical and exercise physiology monitoring. The six precordial leads (V1-V6) are visible across the chest: V1 (4th intercostal space, right sternal border), V2 (4th intercostal space, left sternal border), V3 (midway between V2 and V4), V4 (5th intercostal space, mid-clavicular line), V5 (anterior axillary line), and V6 (mid-axillary line). The leads utilize standard color-coding (Red, Yellow, Green, Brown, Black, Violet). Limb leads are positioned at the shoulders (RA/LA) and the lower ribcage/abdominal area (RL/LL) to facilitate movement during testing. The Polar H10 chest strap is situated inferior to the pectoral muscles, intersecting the mid-precordial electrode line. This visual serves as an educational reference for electrode application in comparative heart rate variability (HRV) studies, highlighting the spatial relationship between traditional medical grade ECG sensors and wearable consumer fitness technology.

Finding Sources
Finding Sources
Searching Images

normal ECG waveform P wave QRS T wave labeled diagram

This diagnostic image displays two 12-lead electrocardiograms (ECGs) labeled Panel A and Panel B, presented on standard grid paper for clinical comparison. Panel A shows a 12-lead ECG demonstrating sinus rhythm with normal P-wave morphology. The QRS complexes exhibit nonspecific intraventricular conduction disturbances, characterized by widened or slurred morphologies in certain leads, notably the precordial leads V1-V6. Panel B shows a subsequent ECG from the same patient. Comparison between the two panels reveals subtle variations in waveform amplitude and ST-segment baseline, though both lack overt ST-segment elevation. The precordial leads (V1-V6) show a typical progression of R-wave amplitude, while lead aVR shows the expected global inversion of P, QRS, and T waves. This comparison is used in cardiology to monitor electrical changes during acute coronary syndromes, such as Non-ST Segment Elevation Myocardial Infarction (NSTEMI), where conduction disturbances may be present despite the absence of classic ST-elevation.

This diagnostic image displays two 12-lead electrocardiograms (ECGs) labeled Panel A and Panel B, presented on standard grid paper for clinical comparison. Panel A shows a 12-lead ECG demonstrating sinus rhythm with normal P-wave morphology. The QRS complexes exhibit nonspecific intraventricular conduction disturbances, characterized by widened or slurred morphologies in certain leads, notably the precordial leads V1-V6. Panel B shows a subsequent ECG from the same patient. Comparison between the two panels reveals subtle variations in waveform amplitude and ST-segment baseline, though both lack overt ST-segment elevation. The precordial leads (V1-V6) show a typical progression of R-wave amplitude, while lead aVR shows the expected global inversion of P, QRS, and T waves. This comparison is used in cardiology to monitor electrical changes during acute coronary syndromes, such as Non-ST Segment Elevation Myocardial Infarction (NSTEMI), where conduction disturbances may be present despite the absence of classic ST-elevation.

This composite educational illustration combines an anatomical diagram of the human heart with a diagnostic Electrocardiogram (ECG) tracing to demonstrate cardiac physiology. On the left, a coronal cross-section of the heart identifies the Aorta, Right Atrium, Left Atrium, Right Ventricle, and Left Ventricle. The right side features a detailed ECG waveform analysis set against a standard measurement grid (1 square = 0.04 sec / 0.1 mV). The tracing identifies key electrophysiological components: the P wave (atrial depolarization), QRS complex (ventricular depolarization), and T wave (ventricular repolarization). Critical diagnostic intervals and segments are explicitly labeled, including the PR interval, PR segment, QRS interval, ST segment, ST interval, QT interval, and the RR interval (representing the heart rate). This comparison chart and pathophysiology diagram serve as an introductory resource for understanding the correlation between cardiac anatomy and the electrical signals recorded during a cardiac cycle, suitable for basic to intermediate medical education.

This composite educational illustration combines an anatomical diagram of the human heart with a diagnostic Electrocardiogram (ECG) tracing to demonstrate cardiac physiology. On the left, a coronal cross-section of the heart identifies the Aorta, Right Atrium, Left Atrium, Right Ventricle, and Left Ventricle. The right side features a detailed ECG waveform analysis set against a standard measurement grid (1 square = 0.04 sec / 0.1 mV). The tracing identifies key electrophysiological components: the P wave (atrial depolarization), QRS complex (ventricular depolarization), and T wave (ventricular repolarization). Critical diagnostic intervals and segments are explicitly labeled, including the PR interval, PR segment, QRS interval, ST segment, ST interval, QT interval, and the RR interval (representing the heart rate). This comparison chart and pathophysiology diagram serve as an introductory resource for understanding the correlation between cardiac anatomy and the electrical signals recorded during a cardiac cycle, suitable for basic to intermediate medical education.

Reading File
Reading File
Searching Images

ECG leads territory coronary artery inferior anterior lateral STEMI localization

This diagnostic image is a 12-lead electrocardiogram (ECG) demonstrating acute ST-segment elevation myocardial infarction (STEMI). The tracing reveals a sinus rhythm with significant ST-segment elevation in the inferior leads (II, III, and aVF) and the anterior precordial leads (V1 through V4), highlighted by red arrows. Notably, there is reciprocal ST-segment depression in the high lateral leads (I and aVL). The anterolateral leads (V5 and V6) show T-wave inversions. These findings indicate widespread myocardial ischemia or injury involving multiple vascular territories, specifically the inferior and anterior walls. The clinical significance of this ECG suggests acute occlusion of major coronary arteries, such as the right coronary artery (RCA) and left anterior descending (LAD) artery, requiring urgent intervention. This visual is an educational example of multi-territory STEMI and the identification of reciprocal changes in a clinical cardiology context.

This diagnostic image is a 12-lead electrocardiogram (ECG) demonstrating acute ST-segment elevation myocardial infarction (STEMI). The tracing reveals a sinus rhythm with significant ST-segment elevation in the inferior leads (II, III, and aVF) and the anterior precordial leads (V1 through V4), highlighted by red arrows. Notably, there is reciprocal ST-segment depression in the high lateral leads (I and aVL). The anterolateral leads (V5 and V6) show T-wave inversions. These findings indicate widespread myocardial ischemia or injury involving multiple vascular territories, specifically the inferior and anterior walls. The clinical significance of this ECG suggests acute occlusion of major coronary arteries, such as the right coronary artery (RCA) and left anterior descending (LAD) artery, requiring urgent intervention. This visual is an educational example of multi-territory STEMI and the identification of reciprocal changes in a clinical cardiology context.

This diagnostic image is a 12-lead electrocardiogram (ECG) demonstrating signs of an acute ST-elevation myocardial infarction (STEMI). The tracing reveals significant ST-segment elevation in the anterior leads (V1-V4) and inferior leads (II, III, and aVF), with black arrows highlighting specific areas of elevation. In lead V2 and V3, the ST-segment shows an upward-sloping, concave morphology, while lead V4 displays a more pronounced, 'tombstone' appearance merging into hyperacute T-waves. Reciprocal ST-segment depression is visible in the lateral leads, specifically I and aVL. The rhythm is sinus, and the heart rate is approximately 75-80 beats per minute. The ECG is clinically significant for multi-territory ischemia, correlating with proximal left anterior descending (LAD) artery occlusion and multi-vessel coronary artery disease. This visual is an essential educational resource for medical students and clinicians for identifying acute coronary syndromes and understanding the distribution of myocardial injury across various cardiac walls.

This diagnostic image is a 12-lead electrocardiogram (ECG) demonstrating signs of an acute ST-elevation myocardial infarction (STEMI). The tracing reveals significant ST-segment elevation in the anterior leads (V1-V4) and inferior leads (II, III, and aVF), with black arrows highlighting specific areas of elevation. In lead V2 and V3, the ST-segment shows an upward-sloping, concave morphology, while lead V4 displays a more pronounced, 'tombstone' appearance merging into hyperacute T-waves. Reciprocal ST-segment depression is visible in the lateral leads, specifically I and aVL. The rhythm is sinus, and the heart rate is approximately 75-80 beats per minute. The ECG is clinically significant for multi-territory ischemia, correlating with proximal left anterior descending (LAD) artery occlusion and multi-vessel coronary artery disease. This visual is an essential educational resource for medical students and clinicians for identifying acute coronary syndromes and understanding the distribution of myocardial injury across various cardiac walls.

This diagnostic image is a 12-lead electrocardiogram (ECG) demonstrating an acute inferior ST-elevation myocardial infarction (STEMI). The tracing reveals significant convex ST-segment elevation in the inferior leads (II, III, and aVF), characteristic of an injury pattern often involving the right coronary artery or left circumflex artery. Accompanying these findings are prominent reciprocal ST-segment depressions in the anterior precordial leads (V1 through V6) and high lateral lead aVL. The rhythm appears to be a normal sinus rhythm with a regular rate. No significant ST-segment deviations are noted in leads I and aVR. This ECG serves as a classic educational example of an inferior STEMI with reciprocal changes, illustrating the electrical changes associated with acute transmural myocardial ischemia in the inferior wall of the heart.

This diagnostic image is a 12-lead electrocardiogram (ECG) demonstrating an acute inferior ST-elevation myocardial infarction (STEMI). The tracing reveals significant convex ST-segment elevation in the inferior leads (II, III, and aVF), characteristic of an injury pattern often involving the right coronary artery or left circumflex artery. Accompanying these findings are prominent reciprocal ST-segment depressions in the anterior precordial leads (V1 through V6) and high lateral lead aVL. The rhythm appears to be a normal sinus rhythm with a regular rate. No significant ST-segment deviations are noted in leads I and aVR. This ECG serves as a classic educational example of an inferior STEMI with reciprocal changes, illustrating the electrical changes associated with acute transmural myocardial ischemia in the inferior wall of the heart.

Reading File
Reading File
Excellent - I now have comprehensive content from Goldman-Cecil Medicine on ECG waves, intervals, and leads. I have everything needed for a complete answer.

The 12-Lead ECG - Complete Guide


What is a 12-Lead ECG?

An electrocardiogram (ECG) records the heart's electrical activity from 12 different vantage points simultaneously, using 10 electrodes (6 chest + 4 limb). Each "lead" is a different angle of view of the same electrical events. Introduced by Einthoven in the early 1900s, it remains one of the most powerful and widely used diagnostic tools in medicine.
  • Goldman-Cecil Medicine, p.511

The ECG Paper

  • Each small box = 0.04 seconds (horizontal) and 0.1 mV (vertical)
  • Each large box = 0.20 seconds (5 small boxes)
  • Standard paper speed = 25 mm/sec
  • Standard calibration = 10 mm = 1 mV

The 10 Electrodes - Placement

Limb Electrodes (4)

ElectrodePlacement
RARight arm (or right shoulder)
LALeft arm (or left shoulder)
RLRight leg - electrical ground only
LLLeft leg

Precordial (Chest) Electrodes (6)

LeadAnatomical Position
V14th intercostal space, right sternal border
V24th intercostal space, left sternal border
V3Midway between V2 and V4
V45th intercostal space, midclavicular line
V5Anterior axillary line (same level as V4)
V6Midaxillary line (same level as V4-V5)
12-lead ECG electrode placement on torso with all 10 electrodes visible

The 12 Leads - What They Look At

The 10 electrodes generate 12 leads (views):

Frontal Plane Leads (Limb Leads)

LeadView of HeartPositive Pole
ILateral wallLeft arm (+) vs Right arm (-)
IIInferior wallLeft leg (+) vs Right arm (-)
IIIInferior wallLeft leg (+) vs Left arm (-)
aVRCavity/rightRight arm (augmented)
aVLHigh lateral wallLeft arm (augmented)
aVFInferior wallLeft leg (augmented)

Horizontal Plane Leads (Precordial / Chest Leads)

LeadView of Heart
V1-V2Septal wall (right ventricle)
V3-V4Anterior wall (LAD territory)
V5-V6Lateral wall (LCx territory)
  • Goldman-Cecil Medicine, p.630

The Normal ECG Waveform

Normal ECG waveform - labeled P wave, QRS, T wave, PR interval, QT interval

Each Wave and What It Represents

ComponentElectrical EventNormal Duration/Value
P waveAtrial depolarization (SA node → atrial muscle)<120 ms; <2.5 mm tall
PR intervalAtrial depol. + AV node conduction delay + His-Purkinje120-200 ms (3-5 small boxes)
QRS complexVentricular depolarization<120 ms (<3 small boxes)
ST segmentEarly ventricular repolarization (isoelectric)At baseline; no elevation/depression
T waveVentricular repolarizationUpright in most leads; asymmetric
QT intervalTotal ventricular electrical activity (depol + repol)Corrected QTc: <450 ms (men), <460 ms (women)
U waveRepolarization of Purkinje fibers (or papillary muscles)Small, same direction as T wave
  • Goldman-Cecil Medicine, p.533-628; Costanzo Physiology 7E, p.4499

Key Notes on the QT Interval

  • Must be rate-corrected (QTc) using Bazett's formula: QTc = QT ÷ √RR
  • Prolonged QTc → risk of Torsades de Pointes (life-threatening VT)
  • Causes of long QT: drugs (antiarrhythmics, antipsychotics, macrolides), hypokalemia, hypomagnesemia, congenital syndromes

Calculating Heart Rate from ECG

Method 1 (regular rhythm):
300 ÷ number of large boxes between two R waves
Method 2 (regular rhythm):
1500 ÷ number of small boxes between two R waves
Method 3 (irregular rhythm):
Count QRS complexes in a 10-second strip × 6
RateInterpretation
60-100 bpmNormal sinus rhythm
<60 bpmBradycardia
>100 bpmTachycardia

Normal Axis and Axis Deviation

The QRS axis reflects the main direction of ventricular depolarization.
AxisRangeMeaning
Normal-30° to +90°Normal
Left axis deviation (LAD)-30° to -90°Left anterior fascicular block, inferior MI, LVH
Right axis deviation (RAD)+90° to +180°RVH, lateral MI, PE, Lposterior fascicular block
Extreme/indeterminate-90° to +/-180°Ventricular tachycardia, dextrocardia
Quick axis check:
  • Lead I positive + aVF positive → Normal axis
  • Lead I positive + aVF negative → LAD
  • Lead I negative + aVF positive → RAD

ECG Localization of MI - Which Leads, Which Artery

TerritoryLeads with ChangesCulprit Artery
AnteriorV1-V4LAD (Left Anterior Descending)
AnteroseptalV1-V2Proximal LAD/septal perforators
AnterolateralV1-V6, I, aVLProximal LAD
LateralI, aVL, V5-V6LCx (Left Circumflex) or Diagonal
InferiorII, III, aVFRCA (Right Coronary Artery) - 80%; LCx - 20%
PosteriorTall R in V1-V2, ST depression V1-V3RCA or LCx
Right ventricleV3R-V4R (right-sided leads)Proximal RCA
Inferior STEMI - ST elevation in II, III, aVF with reciprocal changes in V1-V6 and aVL
Anterior STEMI - ST elevation V1-V4 with reciprocal depression in inferior and lateral leads

Common ECG Abnormalities - Quick Reference

Rate/Rhythm

FindingDiagnosis
Regular P waves, rate 60-100, normal PRNormal sinus rhythm
No P waves, irregularly irregular QRSAtrial fibrillation
Sawtooth flutter waves (~300 bpm), regular 2:1 or 3:1 conductionAtrial flutter
Narrow QRS tachycardia, P before QRSSVT (AVNRT/AVRT)
Wide QRS tachycardia, no P wavesVentricular tachycardia

Conduction

FindingDiagnosis
PR interval >200 ms1st degree AV block
Progressive PR lengthening → dropped QRS2nd degree AV block (Mobitz I / Wenckebach)
Fixed PR, sudden dropped QRS2nd degree AV block (Mobitz II)
No relationship between P and QRSComplete (3rd degree) AV block
Wide QRS (>120ms), RSR' in V1, wide S in V6RBBB
Wide QRS (>120ms), broad R in I, aVL, V5-V6; QS in V1LBBB

Ischemia / Infarction

ECG FindingMeaning
Hyperacute tall T wavesEarliest sign of STEMI (minutes)
ST elevation ≥1 mm in ≥2 contiguous leadsSTEMI
ST depression, T-wave inversionNSTEMI / Unstable angina
Pathological Q waves (>40ms wide, >25% QRS height)Old/completed MI (necrosis)
New LBBB in chest pain settingTreat as STEMI equivalent

Hypertrophy

FindingDiagnosis
P wave >120 ms (bifid), "P mitrale" in lead IILeft atrial enlargement
Tall peaked P in II (>2.5 mm), "P pulmonale"Right atrial enlargement
S in V1 + R in V5 or V6 > 35 mm (Sokolow-Lyon)Left ventricular hypertrophy (LVH)
Tall R in V1-V2, RAD, right strain patternRight ventricular hypertrophy (RVH)

Systematic Approach to Reading Any ECG

Use this order every time:
  1. Rate - calculate from R-R interval
  2. Rhythm - regular/irregular? P before every QRS?
  3. Axis - look at leads I and aVF
  4. P waves - morphology, duration, axis
  5. PR interval - normal 120-200 ms?
  6. QRS - duration, morphology, R wave progression (V1→V6)
  7. ST segment - elevation or depression? Which leads?
  8. T waves - upright, inverted, hyperacute?
  9. QT interval - calculate QTc
  10. U waves - present? (look in V2-V3)

Sources: Goldman-Cecil Medicine International Edition; Costanzo Physiology 7th Edition; Harriet Lane Handbook 23rd Ed.
This is a shared conversation. Sign in to Orris to start your own chat.